Tevogen Bio issues $6M Series A-1 Preferred to existing investor Patel; convertible into 600K common shares

Tevogen Bio Holdings Inc.

Sold 600 shares Series A-1 Preferred Stock at $10,000/share for aggregate $6.0M to The Patel Family, LLP.
Preferred carries 5% annual cumulative dividend increasing 2% yearly (capped at 15%); convertible into 600,000 common shares.
Company has call right if 20-day VWAP > $5.00 and resale registration effective; non-voting, no mandatory redemption.
Investment made under Section 4(a)(2) exemption; existing investor Dr. Manmohan Patel is beneficial owner >5%.
Series A-1 ranks pari passu with Series A, senior to Common and Series B.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.